AI aids T2D insulin dosing
A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration has been found to improve time to optimal insulin dosing, insulin
A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration has been found to improve time to optimal insulin dosing, insulin
The Type 1 Diabetes Grand Challenge – a partnership between the Steve Morgan Foundation, Diabetes UK and JDRF UK – has announced that it has
JDRF have announced that bookings are now open for its free “Managing your Well-being with Type 1 Virtual Discovery Event”, which takes place on Saturday
The French National Agency for Medicines and Health Products Safety (ANSM) has conditionally authorized AMX0035, a new medication developed by the American laboratory Amylyx Pharmaceuticals